(Q44785887)

English

The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C.

scientific article published in March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Thierry Poynard

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Sophie Le Calvez

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Dominique Thabut

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Djamila Messous

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Mona Munteanu

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Vlad Ratziu

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Francoise Imbert-Bismut

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

862-3; author reply 863

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.20099

21 January 2018

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.20099

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.20099

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.20099

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.20099

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.20099

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.20099

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44785887&oldid=1458248683"